1-8 of 8
Darren Pan
Close
Sort by
Journal Articles

Early and Consistent CRS Detection Using Wearable Device for Remote Patient Monitoring Following CAR-T Therapy in Relapsed/Refractory Multiple Myeloma (RRMM): Early Results of an Investigator-Initiated Trial

Sridevi Rajeeve, Nicole Zahradka, Matt Wilkes, Darren Pan, Nicholas J Calafat, Kseniya Serebryakova, Katerina Kappes, Hayley Jackson, Nicole Buchenholz, Sarita Agte, Santiago Thibaud, Larysa Sanchez, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Hearn Jay Cho, Ajai Chari, Sundar Jagannath, Adriana C Rossi, Samir Parekh
Journal: Blood
Blood (2023) 142 (Supplement 1): 1007.
https://doi.org/10.1182/blood-2023-181936
Published: 2023
Journal Articles

Outcomes after CAR T Cells in Multiple Myeloma Patients with Extramedullary and Paramedullary Disease

Darren Pan, Tarek H. Mouhieddine, Weijia Fu, Erin Moshier, Samir Parekh, Sundar Jagannath, Adriana C Rossi, Joshua Richter, Cesar Rodriguez, Larysa J Sanchez, Santiago Thibaud, Hearn Jay Cho, Shambavi Richard
Journal: Blood
Blood (2023) 142 (Supplement 1): 1006.
https://doi.org/10.1182/blood-2023-177749
Published: 2023
Journal Articles

Outcomes with Panobinostat in Heavily Pretreated Multiple Myeloma Patients

Darren Pan, Tarek H. Mouhieddine, Ranjan Upadhyay, Nicole Casasanta, Angela Lee, Nicole Zubizarreta, Erin Moshier, Joshua Richter
Journal: Blood
Blood (2022) 140 (Supplement 1): 12483–12484.
https://doi.org/10.1182/blood-2022-159806
Published: 2022
Journal Articles

Real-World Multiple Myeloma Front-Line Treatment and Outcomes By Transplant in the United States

Joshua Richter, Darren Pan, Taylor Salinardi, Megan S. Rice
Journal: Blood
Blood (2022) 140 (Supplement 1): 7187–7188.
https://doi.org/10.1182/blood-2022-157812
Published: 2022
Journal Articles

Clinical Outcomes and Treatment Strategies for Relapsed/Refractory Myeloma Patients after Relapse on BCMA-Targeted CAR T

Oliver Van Oekelen, Tarek H. Mouhieddine, Darren Pan, Megan Metzger, Sarita Agte, Adolfo Aleman, David T. Melnekoff, Guido Lancman, Alessandro Lagana, Shambavi Richard, Larysa Sanchez, Joshua Richter, Hearn Jay Cho, Ajai Chari, Sundar Jagannath, Samir Parekh
Journal: Blood
Blood (2021) 138 (Supplement 1): 2704.
https://doi.org/10.1182/blood-2021-152243
Published: 2021
Journal Articles

Clinical Outcomes of Relapsed/Refractory Multiple Myeloma Patients Following Treatment with Bispecific Antibodies (BiAbs)

Tarek H. Mouhieddine, Oliver Van Oekelen, Darren Pan, Sarita Agte, Adolfo Aleman, David T. Melnekoff, Guido Lancman, Santiago Thibaud, Larysa Sanchez, Shambavi Richard, Joshua Richter, Hearn Jay Cho, Ajai Chari, Sundar Jagannath, Samir Parekh
Journal: Blood
Blood (2021) 138 (Supplement 1): 821.
https://doi.org/10.1182/blood-2021-151585
Published: 2021
Journal Articles

Outcomes in Multiple Myeloma Patients Progressing on Lenalidomide Maintenance

Larysa Sanchez, MD, Erin Moshier, MS, Alexander Coltoff, MD, Ali Mustafa, MD, Darren Pan, MD BS, Hearn Jay Cho, MD PhD, Sundar Jagannath, MD, Deepu Madduri, MD, Samir Parekh, MD, Shambavi Richard, MD, Joshua Richter, MD, Ajai Chari, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1779.
https://doi.org/10.1182/blood-2019-128441
Published: 2019
Journal Articles

Race, Socioeconomic Status, and Time to Transplantation in Multiple Myeloma

Darren Pan, MD BS, Alexander Coltoff, MD, Umut Ozbek, PhD, Jung-Yi Lin, MS, Solmaz Afshar, BSc, Amir Steinberg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2263.
https://doi.org/10.1182/blood-2018-99-110316
Published: 2018